Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$10.2 million.

  • Gossamer Bio's Other Working Capital Changes fell 29532.64% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year decrease of 12119.19%. This contributed to the annual value of $55.9 million for FY2024, which is 133676.77% up from last year.
  • Per Gossamer Bio's latest filing, its Other Working Capital Changes stood at -$10.2 million for Q3 2025, which was down 29532.64% from $6.8 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Other Working Capital Changes registered a high of $65.9 million during Q2 2024, and its lowest value of -$10.2 million during Q3 2025.
  • For the 4-year period, Gossamer Bio's Other Working Capital Changes averaged around $3.8 million, with its median value being $801000.0 (2024).
  • As far as peak fluctuations go, Gossamer Bio's Other Working Capital Changes tumbled by 46295.22% in 2023, and later surged by 234689.94% in 2024.
  • Over the past 4 years, Gossamer Bio's Other Working Capital Changes (Quarter) stood at $691000.0 in 2022, then tumbled by 462.95% to -$2.5 million in 2023, then plummeted by 226.48% to -$8.2 million in 2024, then dropped by 25.0% to -$10.2 million in 2025.
  • Its last three reported values are -$10.2 million in Q3 2025, $6.8 million for Q2 2025, and -$1.4 million during Q1 2025.